Empirical Finance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
1,927
+298
| +18% | +$156K | 0.05% | 292 |
|
|
2025
Q1 | $1.03M | Sell |
1,629
-2
| -0.1% | -$1.27K | 0.06% | 267 |
|
|
2024
Q4 | $1.16M | Sell |
1,631
-48
| -3% | -$34.2K | 0.07% | 241 |
|
|
2024
Q3 | $1.77M | Sell |
1,679
-61
| -4% | -$64.1K | 0.1% | 173 |
|
|
2024
Q2 | $1.83M | Sell |
1,740
-236
| -12% | -$248K | 0.11% | 159 |
|
|
2024
Q1 | $1.9M | Sell |
1,976
-12
| -0.6% | -$11.6K | 0.12% | 163 |
|
|
2023
Q4 | $1.75M | Sell |
1,988
-2
| -0.1% | -$1.76K | 0.12% | 159 |
|
|
2023
Q3 | $1.64M | Sell |
1,990
-1
| -0.1% | -$823 | 0.12% | 153 |
|
|
2023
Q2 | $1.43M | Sell |
1,991
-673
| -25% | -$484K | 0.11% | 166 |
|
|
2023
Q1 | $2.19M | Buy |
2,664
+106
| +4% | +$87.1K | 0.21% | 104 |
|
|
2022
Q4 | $1.85M | Buy |
2,558
+240
| +10% | +$173K | 0.19% | 111 |
|
|
2022
Q3 | $1.6M | Buy |
2,318
+441
| +23% | +$304K | 0.19% | 112 |
|
|
2022
Q2 | $1.11M | Buy |
1,877
+776
| +70% | +$459K | 0.14% | 139 |
|
|
2022
Q1 | $769K | Buy |
1,101
+220
| +25% | +$154K | 0.09% | 220 |
|
|
2021
Q4 | $556K | Buy |
881
+509
| +137% | +$321K | 0.07% | 275 |
|
|
2021
Q3 | $225K | Buy |
+372
| New | +$225K | 0.03% | 396 |
|
|
2017
Q1 | – | Sell |
-44
| Closed | -$17K | – | 465 |
|
|
2016
Q4 | $17K | Buy |
+44
| New | +$17K | 0.01% | 222 |
|